Consensus RadNet, Inc. Deutsche Boerse AG

Stocks

PQIA

US7504911022

Healthcare Facilities & Services

Real-time Estimate Tradegate 10:23:16 02/10/2026 BST			5-day change	1st Jan Change
60.48 ^EUR	-1.18%		-3.86%	-2.89%

10-01	RadNet, WIN-NextGen Collaborating on Medical Imaging Career Initiative	MT
09-16	RadNet, Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-16-2026 07:45 AM

e18b8227b7b1e5a9.L-cN11j_DHMcAwPPa2GdwVV4ZuVn8NuJrHVZ3zpGgso.Wtc0sGGLawdVcUKsBhjx8QYZVbohl7zH6yBrmAgk45wC11rnCKBpRFRARg~4b2f1d8d5f9c0bed0ddfb045e54f263a

Analysts' recommendations: RadNet, Inc.

08-11	B. Riley Adjusts Price Target on RadNet to $96 From $83, Maintains Buy Rating	MT
08-11	Truist Adjusts Price Target on RadNet to $94 From $90, Maintains Buy Rating	MT
05-01	B. Riley Adjusts Price Target on RadNet to $83 From $87, Maintains Buy Rating	MT
12-01	B. Riley Raises Price Target on RadNet to $87 From $71, Keeps Buy Rating	MT
11-12	Truist Raises Price Target on RadNet to $90 From $81, Keeps Buy Rating	MT
03/09/25	Truist Raises Price Target on RadNet to $81 From $74, Keeps Buy Rating	MT
12/08/25	B. Riley Adjusts Price Target on RadNet to $71 From $69, Maintains Buy Rating	MT
13/06/25	B. Riley Initiates RadNet at Buy With $69 Price Target	MT
17/04/25	RadNet's iCAD Deal to Expand its Digital Health Services and Geographic Presence, Truist Says	MT
11/04/25	Truist Securities Cuts Price Target on RadNet to $74 From $88, Keeps Buy Rating	MT
22/01/25	Truist Securities Cuts Price Target on RadNet to $88 From $94, Keeps Buy Rating	MT
29/11/24	Truist Raises Price Target on RadNet to $94 From $80, Keeps Buy Rating	MT
11/11/24	Top Midday Gainers	MT
04/10/24	Sidoti Adjusts RadNet Price Target to $88 From $72, Maintains Buy Rating	MT
23/09/24	Truist Raises Price Target on RadNet to $80 From $70, Maintains Buy Rating	MT
06/09/24	Barclays Upgrades RadNet to Overweight From Equal Weight	MT
15/07/24	Truist Securities Adjusts Price Target on RadNet to $70 From $63, Maintains Buy Rating	MT
11/07/24	Jefferies Adjusts Price Target on RadNet to $75 From $61, Maintains Buy Rating	MT
15/05/24	Truist Securities Adjusts Price Target on RadNet to $63 From $55, Maintains Buy Rating	MT
28/03/24	Truist Securities Raises Price Target on RadNet to $55 From $51, Maintains Buy Rating	MT
06/03/24	Barclays Starts Coverage on RadNet With Equalweight Rating, $48 Price Target	MT
04/03/24	Truist Securities Adjusts RadNet Price Target to $51 From $42, Maintains Buy Rating	MT
08/12/23	Truist Adjusts RadNet's Price Target to $42 From $40, Maintains Buy Rating	MT
31/08/23	Truist Securities Starts RadNet at Buy With $40 Price Target	MT
26/06/23	Raymond James Raises Price Target on RadNet to $40 From $35, Keeps Outperform Rating	MT

More recommendations

Medical & Diagnostic Laboratories

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	CVS HEALTH CORPORATION					+36.48%
	HCA HEALTHCARE, INC.					+7.28%
	NATERA, INC.					-12.86%
	FRESENIUS SE & CO. KGAA					+26.91%
	QUEST DIAGNOSTICS INCORPORATED					+7.2%
	LABCORP HOLDINGS INC.					+13.2%
	DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY					+19.46%
	TENET HEALTHCARE CORPORATION					+12.07%
	IHH HEALTHCARE					+32.89%
	Average					+15.85%
	Weighted average by Cap.					+16.04%